Mallolas J - Search Results

1

Evolution of Risk Behaviors, Sexually Transmitted Infections and PrEP Care Continuum in a Hospital-Based PrEP Program in Barcelona, Spain: A Descriptive Study of the First 2 Years' Experience.

Ugarte A, de la Mora L, García D, Martínez-Rebollar M, de Lazzari E, Torres B, Inciarte A, Ambrosioni J, Chivite I, Solbes E, de Loredo N, Del Carlo GF, González-Cordón A, Blanco JL, Martínez E, Mallolas J, Laguno M. Ugarte A, et al. Among authors: mallolas j. Infect Dis Ther. 2023 Feb;12(2):425-442. doi: 10.1007/s40121-022-00733-6. Epub 2022 Dec 15. Infect Dis Ther. 2023. PMID: 36520330 Free PMC article.

2

[Comparison of three methods to calculate adherence in patients receiving antiretroviral treatment].

Codina C, Martínez M, Tuset M, del Cacho E, Martín MT, Miró JM, Mallolas J, de Lazzari E, García F, Martínez E, Gatell JM, Ribas J. Codina C, et al. Among authors: mallolas j. Enferm Infecc Microbiol Clin. 2002 Dec;20(10):484-90. doi: 10.1016/s0213-005x(02)72850-4. Enferm Infecc Microbiol Clin. 2002. PMID: 12433349 Spanish.

3

Metabolic and immunological effects of antiretroviral agents in healthy individuals receiving post-exposure prophylaxis.

Garcia F, Plana M, Mestre G, Cruceta A, Martinez E, Miró JM, Mallolas J, Tuset M, Pumorola T, Gallart T, Gatell JM. Garcia F, et al. Among authors: mallolas j. Antivir Ther. 2002 Sep;7(3):195-7. Antivir Ther. 2002. PMID: 12487387 Clinical Trial.

4

Predictors of tonsillar tissue HIV-1 viral burden at baseline and after 1 year of antiretroviral therapy.

Navarrete P, Morente V, García F, Alós L, Arnedo M, Plana M, Gil C, Caballero M, Miró JM, Martínez E, Fumero E, Castro P, Blanco JL, Mallolas J, Blanch JL, Cruceta A, Mestre G, Pumarola T, Gallart T, Gatell JM. Navarrete P, et al. Among authors: mallolas j. Antivir Ther. 2003 Dec;8(6):635-7. Antivir Ther. 2003. PMID: 14760898

5

Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell count.

García F, de Lazzari E, Plana M, Castro P, Mestre G, Nomdedeu M, Fumero E, Martínez E, Mallolas J, Blanco JL, Miró JM, Pumarola T, Gallart T, Gatell JM. García F, et al. Among authors: mallolas j. J Acquir Immune Defic Syndr. 2004 Jun 1;36(2):702-13. doi: 10.1097/00126334-200406010-00007. J Acquir Immune Defic Syndr. 2004. PMID: 15167289

6

Pancreatic toxic effects associated with co-administration of didanosine and tenofovir in HIV-infected adults.

Martínez E, Milinkovic A, de Lazzari E, Ravasi G, Blanco JL, Larrousse M, Mallolas J, García F, Miró JM, Gatell JM. Martínez E, et al. Among authors: mallolas j. Lancet. 2004 Jul 3-9;364(9428):65-7. doi: 10.1016/S0140-6736(04)16591-4. Lancet. 2004. PMID: 15234858

7

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients.

Laguno M, Murillas J, Blanco JL, Martínez E, Miquel R, Sánchez-Tapias JM, Bargallo X, García-Criado A, de Lazzari E, Larrousse M, León A, Loncá M, Milinkovic A, Gatell JM, Mallolas J. Laguno M, et al. Among authors: mallolas j. AIDS. 2004 Sep 3;18(13):F27-36. doi: 10.1097/00002030-200409030-00003. AIDS. 2004. PMID: 15316335 Clinical Trial.

8

Gynecomastia among HIV-infected patients is associated with hypogonadism: a case-control study.

Biglia A, Blanco JL, Martínez E, Domingo P, Casamitjana R, Sambeat M, Milinkovic A, Garcia M, Laguno M, Leon A, Larrousse M, Lonca M, Mallolas J, Gatell JM. Biglia A, et al. Among authors: mallolas j. Clin Infect Dis. 2004 Nov 15;39(10):1514-9. doi: 10.1086/425363. Epub 2004 Oct 25. Clin Infect Dis. 2004. PMID: 15546089

9

Depressive symptoms after initiation of interferon therapy in human immunodeficiency virus-infected patients with chronic hepatitis C.

Laguno M, Blanch J, Murillas J, Blanco JL, León A, Lonca M, Larrousse M, Biglia A, Martinez E, García F, Miró JM, de Pablo J, Gatell JM, Mallolas J. Laguno M, et al. Among authors: mallolas j. Antivir Ther. 2004 Dec;9(6):905-9. Antivir Ther. 2004. PMID: 15651749

10

Early virological failure in treatment-naive HIV-infected adults receiving didanosine and tenofovir plus efavirenz or nevirapine.

León A, Martinez E, Mallolas J, Laguno M, Blanco JL, Pumarola T, Gatell JM. León A, et al. Among authors: mallolas j. AIDS. 2005 Jan 28;19(2):213-5. doi: 10.1097/00002030-200501280-00017. AIDS. 2005. PMID: 15668550

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

383 results

Search Page